Drawing for DOMAIN THERAPEUTICS

USPTO serial 87643534

DOMAIN THERAPEUTICS

Reviewed by CopyMark Law Group

Reg. 5598773Status 705Registered
Filing date
Status date
Registration date
Nov 6, 2018
Examiner
FOSDICK, GEOFFREY A
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights. Track next renewal deadlines in TSDR and WIPO records.

Status 705: Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights.

Need help with DOMAIN THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey M. Goehring

Jeffrey M. Goehring Nixon & Vanderhye P.C.901 N. Glebe Road, 11th FloorArlington, VA 22203United States

Goods and services

ClassDescriptionStatusFirst use
001[ Chemicals used in the biological, biotechnological, medical, pharmaceutical, and veterinary industries; biological preparations for use in the biological, biotechnological, medical, pharmaceutical, and veterinary industries ]SECTION 8 - CANCELLED—
005[ Pharmaceutical and veterinary pharmaceutical preparations acting on the central nervous system; pharmaceutical and veterinary pharmaceutical preparations for treating cancer, neurologic diseases, psychiatric diseases, metabolic diseases, inflammatory diseases, cardiovascular diseases; pharmaceutical and veterinary pharmaceutical preparations for the treatment of pain ]SECTION 8 - CANCELLED—
009[ Scientific apparatus and instruments, for the measurement of biological, pharmacological, psychological or chemical phenomena for performing cellular, phenotypic, biochemical, binding and functional assays ]SECTION 8 - CANCELLED—
010[ Medical apparatus and instruments for targeting membrane proteins for tissue-based diagnostic testing, cytology and cell-based testing ]SECTION 8 - CANCELLED—
042Scientific research and development relating to molecules for therapeutic use; scientific research and development relating to new procedures and experiments for discovering, identifying or improving molecules for therapeutic use; scientific laboratory and engineering services for developing molecule for therapeutic useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 12, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Mar 12, 2025C15PREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Mar 12, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 12, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Nov 6, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Mar 23, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 23, 2022ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Mar 23, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 23, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 6, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 21, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 21, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 1, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 12, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 11, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 11, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 11, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 23, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 23, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 23, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 22, 2018DOCKASSIGNED TO EXAMINER—
Oct 21, 2017MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Oct 20, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 16, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance